Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 343 for “"aromatase"”.

  1. Metabolic effects of aromatase inhibition

    Aromatase, a member of the cytochrome P450 superfamily, catalyses the conversion of androgens to estrogens; specifically, testosterone to estradiol and androstenedione to estrone. Aromatase is widely expressed across a range of tissues and deleterious metabolic effects are observed in both murine …

    edinburgh Repository record for Metabolic effects of aromatase inhibition (opens in a new tab)

  2. The chemistry and biochemistry of aromatase inhibitors.

    Aromatase is the last enzyme in estrogenesis, and as such is of central importance in estrogen metabolic and reproductive processes. Four central postulates of aromatase active site topology were elaborated: 1. The C-19 cavity postulate predicted that a cavity exists in aromatase. Steroids …

    ottawa-retro Repository record for The chemistry and biochemistry of aromatase inhibitors. (opens in a new tab)

  3. Tamoxifen metabolites can target both aromatase and estrogen receptors

    … estrogen receptor down-regulators (SERDs) and aromatase inhibitors (AIs). However, the efficacy and safety of SERMs, SERDs and AIs are compromised by side effects or tumor resistance. One possible way of improving treatment efficacy and safety profiles is to develop agents with dual aromatase …

    iupui Repository record for Tamoxifen metabolites can target both aromatase and estrogen receptors (opens in a new tab)

  4. Use of an aromatase inhibitor for ovarian synchronization in cattle

    Letrozole is a third-generation aromatase inhibitor approved for use in post-menopausal women to treat hormone-responsive breast cancer. Letrozole is used off-label in women for the induction of ovulation and for use in ovarian stimulation. The overall objective of this thesis was to determine the …

    sask Repository record for Use of an aromatase inhibitor for ovarian synchronization in cattle (opens in a new tab)

  5. Spectroscopic characterization of iron-oxygen intermediates in human aromatase (CYP19A1)

    CYP19A1 or aromatase, is a human steroidogenic P450 important for estrogen biosynthesis in humans. Over activation of aromatase results in malignancies of the breast tissue, especially in post menopausal women. In fact, aromatase inhibitors constitute the front line therapy for estrogen receptor …

    uiuc Repository record for Spectroscopic characterization of iron-oxygen intermediates in human aromatase (CYP19A1) (opens in a new tab)

  6. Effects of a Non-Steroidal Aromatase Inhibitor on Human Ovarian Function

    … of better contraceptive and fertility protocols. Aromatase inhibitors cause a transient decline in natural estrogen production. Multiple small doses of an aromatase inhibitor have been used during fertility therapy to induce dominant follicle growth and ovulation. Objectives: Our objectives were …

    sask Repository record for Effects of a Non-Steroidal Aromatase Inhibitor on Human Ovarian Function (opens in a new tab)

  7. Understanding Aromatase: A Mechanistic Basis for Drug Interactions and New Inhibitors

    Aromatase is the cytochrome P450 enzyme that converts androgens to estrogens. Aromatase is the target of the aromatase inhibitor class of drugs widely used to treat estrogen-mediated conditions including breast cancer. Little is known about the role of this enzyme in drug metabolism or in drug …

    iupui Repository record for Understanding Aromatase: A Mechanistic Basis for Drug Interactions and New Inhibitors (opens in a new tab)

  8. Cytoplasmic Cyclin E Mediates Resistance to Aromatase Inhibitors In Breast Cancer

    … hormone receptors and need hormonal therapy. Aromatase inhibitors (AIs) block estrogen biosynthesis and are considered as the first line hormonal therapy for ER+ post-menopausal patients. However, resistance to these drugs remains a major challenge in clinic and the biology of such resistance …

    uthsc Repository record for Cytoplasmic Cyclin E Mediates Resistance to Aromatase Inhibitors In Breast Cancer (opens in a new tab)

  9. Obesity and postmenopausal breast cancer : determining the role of local aromatase expression

    … inflammation, which can stimulate adipose tissue aromatase expression and subsequent estrogen production. Given that obese patients have a lower response rate to aromatase inhibitor treatment and greater mammary tissue aromatase levels, it was hypothesized that obesity promotes ER alpha positive …

    texas Repository record for Obesity and postmenopausal breast cancer : determining the role of local aromatase expression (opens in a new tab)

  10. Effects of a non-steroidal aromatase inhibitor on ovarian function in cattle

    … to characterize the effects of a non-steroidal aromatase inhibitor, letrozole, on ovarian function in cattle. The specific objective was to test the hypothesis that letrozole will arrest dominant follicle growth resulting in emergence of a new follicular wave at a predictable interval …

    sask Repository record for Effects of a non-steroidal aromatase inhibitor on ovarian function in cattle (opens in a new tab)

  11. MODULATION OF AROMATASE EXPRESSION BY ANDROGEN RECEPTORS IN THE AFRICAN CICHLID Astatotilapia burtoni

    … the expression of cyp19a1, a brain-specific aromatase, in the brains of male and female A. burtoni lacking a functional ARa gene. Specifically focusing on brain regions within the social behavior network (SBN) which are key in the production of social behavior. We found that cyp19a1 …

    houston Repository record for MODULATION OF AROMATASE EXPRESSION BY ANDROGEN RECEPTORS IN THE AFRICAN CICHLID Astatotilapia burtoni (opens in a new tab)

  12. Aromatase inhibitor use, co-morbidities, and cardiovascular disease risk in breast cancer survivors

    … and can be treated by endocrine therapy. Aromatase inhibitors (AIs) and tamoxifen are the two major types of endocrine therapies. Although AIs have more favorable breast cancer clinical outcomes than tamoxifen, AI-related cardiovascular disease (CVD) risk is a growing concern. Previous …

    washington Repository record for Aromatase inhibitor use, co-morbidities, and cardiovascular disease risk in breast cancer survivors (opens in a new tab)

  13. Effects of the aromatase inhibitor fadrozole on gene expression in the zebrafish brain

    Aromatase is responsible for the conversion of androgens to estrogens in the brain and gonadal tissues. Teleosts have been characterized as having high levels of brain estrogen biosynthesis. Little is known about the effects of estrogens on brain function in teleosts. The main objective of this …

    ottawa-retro Repository record for Effects of the aromatase inhibitor fadrozole on gene expression in the zebrafish brain (opens in a new tab)

  14. Association of aromatase (TTTA)n repeat polymorphisms with central precocious puberty in girls.

    … cytochrome P450 19A1 (CYP19A1) gene encodes an aromatase that is responsible for the conversion of androgens to estrogen, which is key step in estrogen biosynthesis. The aim of this study is to identify CYP19A1 gene mutations or polymorphisms in girls with central precocious puberty (CPP). …

    ajou Repository record for Association of aromatase (TTTA)n repeat polymorphisms with central precocious puberty in girls. (opens in a new tab) Embargoed until 9999-12-31

  15. The role of IFITM1 in promoting breast cancer aggression and aromatase-inhibitor resistance

    … is produced from precursor hormones by the aromatase enzyme, whose action can be blocked with aromatase inhibitors (AIs). Unfortunately ~40% of breast cancer patients are resistant to this treatment and their breast tumors either continue to grow or recur despite depletion of circulating …

    ku Repository record for The role of IFITM1 in promoting breast cancer aggression and aromatase-inhibitor resistance (opens in a new tab)

Page 1 of 18